Abbvie reported $4.49B in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2447M 458M
Abbvie ABBV:US $ 4490M 446M
Amgen AMGN:US $ 1476M 423M
AstraZeneca AZN:LN 386M 733M
Astrazeneca AZN:US $ 386M 733M
Biogen BIIB:US $ 303.8M 64.4M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Chemocentryx CCXI:US $ -38.61M 1.92M
Coherus Biosciences CHRS:US $ -96.08M 50.36M
Eisai 4523:JP Y -12403M 26575M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Gilead Sciences GILD:US $ 19M 363M
GlaxoSmithKline GSK:LN 1802M 1053M
Horizon Pharma HZNP:US $ 204.26M 31.08M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
JAZZ PHA JAZZ:US $ 1.65M 37M
Medtronic MDT:US $ 1486M 7M
Merk MRK:US $ 4310M 552M
Novartis NOVN:VX SF 2222M 14086M
Pacira Pharmaceuticals PCRX:US $ 6.83M 11.96M
Teva Pharmaceutical Industries TEVA:US $ -955M 797M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
United Therapeutics UTHR:US $ 239.9M 127.7M
Zoetis ZTS:US $ 595M 181M